Target intelligence / Profile preview

Cellular macromolecules and organelles

Molecular classification
Other
01

Overview

Cellular macromolecules and organelles constitute the fundamental structural and functional units of biological systems, including proteins, nucleic acids, lipids, carbohydrates, and specialized compartments such as mitochondria, ribosomes, and the nucleus (National Center for Biotechnology Information [NCBI], 2023). These entities orchestrate all vital cellular processes, from the replication of genetic material and protein synthesis to energy metabolism and signal transduction (StatPearls, 2023). While drug discovery typically focuses on specific molecular targets, many therapeutic classes act by broadly affecting these components; for example, alkylating agents modify DNA macromolecules, and certain antibiotics disrupt the structural integrity of the bacterial cell wall or ribosomal machinery (PubMed, 2022). Dysfunctions within these macromolecules and organelles are central to the etiology of diverse pathologies, including oncogenesis, metabolic disorders, and neurodegeneration (NIH, 2021). Because this term encompasses nearly all biological matter within a cell, it is classified as a high-level biological category rather than a specific, druggable receptor or enzyme. Understanding the interplay between drugs and these cellular components is essential for evaluating systemic toxicity and the broad mechanisms of action of multi-target therapeutics (Nature Reviews Drug Discovery, 2006).

Other names
Cellular componentsBiological macromoleculesSubcellular structuresSubcellular organelles
02

Mechanism of action

Drugs targeting these components act through various mechanisms such as DNA intercalation, inhibition of protein synthesis, disruption of membrane integrity, or modulation of organelle-specific metabolic pathways (PubMed, 2022; Nature Reviews Drug Discovery, 2006).

03

Biological functions

Cellular homeostasisMetabolismSignal transductionGenetic information storageEnergy productionProtein synthesisStructural integrity
04

Disease associations

CancerNeurodegenerative diseaseMetabolic disorderInfectionOther
05

Safety considerations

Systemic toxicityLack of target specificityPotential for widespread off-target effectsDisruption of essential cellular homeostasisGenotoxicity
06

Interacting drugs

Doxorubicin

4 more in the full profile.

07

Biomarkers

Mitochondrial DNA (mtDNA)Lysosomal enzymesSpecific protein expression levelsMicrosatellite instability

Beyond the preview

Go deeper on Cellular macromolecules and organelles.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cellular macromolecules and organelles.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call